chr1-183944302-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015101.4(COLGALT2):āc.1291A>Cā(p.Lys431Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,613,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.0000068 ( 0 hom. )
Consequence
COLGALT2
NM_015101.4 missense
NM_015101.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
COLGALT2 (HGNC:16790): (collagen beta(1-O)galactosyltransferase 2) Predicted to enable procollagen galactosyltransferase activity. Predicted to be involved in collagen fibril organization. Predicted to be located in endoplasmic reticulum lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12053043).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COLGALT2 | NM_015101.4 | c.1291A>C | p.Lys431Gln | missense_variant | 10/12 | ENST00000361927.9 | |
COLGALT2 | NM_001303420.2 | c.1291A>C | p.Lys431Gln | missense_variant | 10/12 | ||
COLGALT2 | NM_001303421.2 | c.931A>C | p.Lys311Gln | missense_variant | 10/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COLGALT2 | ENST00000361927.9 | c.1291A>C | p.Lys431Gln | missense_variant | 10/12 | 1 | NM_015101.4 | P1 | |
COLGALT2 | ENST00000649786.1 | c.1291A>C | p.Lys431Gln | missense_variant | 10/12 | ||||
COLGALT2 | ENST00000367520.3 | c.502A>C | p.Lys168Gln | missense_variant | 5/7 | 2 | |||
COLGALT2 | ENST00000367521.5 | c.115A>C | p.Lys39Gln | missense_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250004Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135120
GnomAD3 exomes
AF:
AC:
8
AN:
250004
Hom.:
AF XY:
AC XY:
5
AN XY:
135120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1460988Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 726772
GnomAD4 exome
AF:
AC:
10
AN:
1460988
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
726772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360
GnomAD4 genome
AF:
AC:
3
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.1291A>C (p.K431Q) alteration is located in exon 10 (coding exon 10) of the COLGALT2 gene. This alteration results from a A to C substitution at nucleotide position 1291, causing the lysine (K) at amino acid position 431 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T
Sift4G
Benign
.;T;T;T
Polyphen
0.15, 0.24
.;.;B;B
Vest4
0.30, 0.47, 0.30
MutPred
Loss of ubiquitination at K431 (P = 0.0283);.;Loss of ubiquitination at K431 (P = 0.0283);.;
MVP
0.75
MPC
0.36
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at